Kymera Therapeutics Ownership | Who Owns Kymera Therapeutics?
Kymera Therapeutics Ownership Summary
Kymera Therapeutics is owned by 99.31% institutional investors, 2.50% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 8.27% of KYMR shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 4.14% of its assets in Kymera Therapeutics shares.
KYMR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kymera Therapeutics | 99.31% | 2.50% | -1.80% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 6.65M | 8.27% | $376.47M |
| Avoro capital advisors | 6.35M | 7.89% | $359.41M |
| Fmr | 5.88M | 7.31% | $332.79M |
| Bvf inc/il | 5.50M | 6.84% | $311.45M |
| Vanguard group | 5.42M | 6.74% | $306.87M |
| Wellington management group llp | 5.20M | 6.46% | $294.08M |
| Price t rowe associates inc /md/ | 5.10M | 6.34% | $288.51M |
| Atlas venture life science advisors | 4.90M | 6.09% | $277.14M |
| Blackrock | 4.16M | 5.87% | $124.04M |
| Blackrock funding, inc. /de | 4.37M | 5.43% | $247.08M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 4.90M | 36.82% | $277.14M |
| Aju ib investment | 457.06K | 22.47% | $25.86M |
| Merck | 772.16K | 19.17% | $43.70M |
| Bvf inc/il | 5.50M | 12.63% | $311.45M |
| Siren | 3.43M | 7.59% | $194.03M |
| Aquilo capital management | 138.52K | 6.80% | $3.79M |
| Boxer capital management | 319.10K | 5.76% | $18.06M |
| Avoro capital advisors | 6.35M | 4.65% | $359.41M |
| Foresite capital management vi | 146.33K | 3.20% | $8.28M |
| Octagon capital advisors lp | 360.00K | 3.09% | $20.38M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Holocene advisors, lp | 840.33K | 0.11% | 840.33K |
| Alyeska investment group | 615.09K | 0.11% | 565.09K |
| Federated hermes | 558.70K | 0.06% | 558.70K |
| T. rowe price investment management | 611.22K | 0.02% | 520.59K |
| Blackrock | 4.16M | 0.00% | 499.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Price t rowe associates inc /md/ | 5.10M | 0.03% | -1.76M |
| Redmile group | - | - | -803.29K |
| Deep track capital, lp | - | - | -600.33K |
| Avidity partners management lp | - | - | -500.00K |
| First light asset management | - | - | -383.31K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Holocene advisors, lp | 840.33K | 0.11% | 840.33K | $47.56M |
| Federated hermes | 558.70K | 0.06% | 558.70K | $31.62M |
| First turn management | 277.73K | 2.36% | 277.73K | $15.72M |
| Braidwell lp | 276.69K | 0.46% | 276.69K | $15.66M |
| Logos global management lp | 250.00K | 1.27% | 250.00K | $14.15M |
Sold Out
| Holder | Change |
|---|---|
| Global financial private client | -1.00 |
| Financial gravity asset management | -2.00 |
| Capital performance advisors llp | -3.00 |
| True wealth design | -6.00 |
| Riggs asset managment | -7.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 208 | -0.95% | 79,891,044 | 2.85% | 99 | 1.07% | 117 | -10.00% | 53 | 6.00% |
| Jun 30, 2025 | 215 | 18.78% | 78,776,956 | 8.20% | 97 | 1.19% | 132 | 48.31% | 52 | -7.14% |
| Mar 31, 2025 | 20 | -89.07% | 22,191,205 | -69.06% | 27 | 0.31% | 7 | -92.39% | 4 | -93.10% |
| Dec 31, 2024 | 180 | -0.55% | 71,156,642 | 3.18% | 93 | 1.14% | 88 | -4.35% | 59 | -4.84% |
| Sep 30, 2024 | 181 | 16.03% | 68,964,551 | 2.37% | 90 | 1.00% | 93 | 6.90% | 62 | 31.91% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 2.90M | 4.14% | -150.42K |
| T. Rowe Price New Horizons | 2.67M | 3.73% | -236.19K |
| Fidelity Growth Compy Commingled Pl O | 2.24M | 3.46% | 52.60K |
| Vanguard Health Care Inv | 2.39M | 3.40% | -626.58K |
| Fidelity Growth Compy Commingled Pl S | 2.36M | 3.29% | 14.03K |
| Vanguard Total Stock Mkt Idx Inv | 1.88M | 2.66% | -39.75K |
| Vanguard US Total Market Shares ETF | 1.54M | 2.38% | 1.91K |
| Fidelity Growth Company Fund | 1.64M | 2.30% | -2.90K |
| Vanguard Small Cap Index | 1.45M | 2.05% | -9.73K |
| T. Rowe Price Health Sciences | 1.20M | 1.69% | -161.06K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | Buy | $158.12M | |
| Dec 11, 2025 | BAKER BROS. ADVISORS LP | Buy | $14.38M | |
| Dec 08, 2025 | Albers Jeffrey W. | - | Sell | $245.46K |
| Dec 08, 2025 | Albers Jeffrey W. | - | Sell | $203.36K |
| Dec 08, 2025 | Mainolfi Nello | Chief Executive Officer | Sell | $8.92M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | 2 | 18 |
| 2025 Q3 | - | 2 |
| 2025 Q2 | 7 | 7 |
| 2025 Q1 | - | 9 |
| 2024 Q4 | - | 1 |
KYMR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools